GSK-3

GSK3 (glycogen synthase kinase-3) is a serine/threonine protein kinase which contributes to cell survival, diabetes, insulin resistance and Alzheimer's diseases.

Products Related to GSK-3(59)

GC69196 GSK3 Substrate, α, β subunit
Purity: >98%
GSK3 Substrate, α, β subunit is a peptide substrate of glycogen synthase kinase-3 (GSK-3) that can be used to measure GSK-3 activity.
GC70708 6-Me-ATP trisodium
Purity: >99.00%
6-Me-ATP (N6-Methyl-ATP) trisodium is a N6-modified ATP derivative.
GC72931 HTH-01-091 TFA
Purity: >98.00%
HTH-01-091 TFA is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM.
GC73063 Tagtociclib hydrate
CAS: 2733575-91-0
Purity: >99.00%
PF-07104091 drate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively.
GC73183 CDK8-IN-12
CAS: 2613307-67-6
Purity: >99.00%
CDK8-IN-12 is an orally active, potent CDK8 inhibitor with a Ki of 14 nM.
GC74261 (R)-(+)-O-Demethylbuchenavianine
CAS: 1364123-68-1
Purity: >98.00%
(R)-(+)-O-Demetlbuchenavianine is an inhibitor for Cyclin-dependent kinases (CDK).
GC79117 8012–3246
CAS: 421586-94-9
Purity: >99.50%
8012-3246 is a selective PLK2 inhibitor with an IC 50 of 774.5 nM.
GC79759 SkQR1 hydroxide
CAS: 1333381-77-3
Purity: >98%
SkQR1 hydroxide is a mitochondrial targeted antioxidant.
GC80870 XL-418
CAS: 871343-09-8
Purity: >95.00%
XL-418 is an orally active dual Akt and p70S6K inhibitor with IC 50 s of 1 nM for Akt1 and 2 nM for p70S6K.
GC80873 Tovophyllin A
CAS: 40738-44-1
Purity: >98%
Tovophyllin A is an orally active xanthonoid compound.
GC80874 ARN25699
Purity: >98%
ARN25699 is a kinase inhibitor with an IC 50 of 5.5 nM against GSK-3β, 2.2 nM against FYN-α, and 242.3 nM against DYRK1A, and it exhibits oral bioavailability.

Category Product List
Catalog No.	Product Name	CAS No.	Purity
GC69196	GSK3 Substrate, α, β subunit	-	>98%
GC69196	GSK3 Substrate, α, β subunit is a peptide substrate of glycogen synthase kinase-3 (GSK-3) that can be used to measure GSK-3 activity.
GC70708	6-Me-ATP trisodium	-	>99.00%
GC70708	6-Me-ATP (N6-Methyl-ATP) trisodium is a N6-modified ATP derivative.
GC72931	HTH-01-091 TFA	-	>98.00%
GC72931	HTH-01-091 TFA is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM.
GC73063	Tagtociclib hydrate	2733575-91-0	>99.00%
GC73063	PF-07104091 drate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively.
GC73183	CDK8-IN-12	2613307-67-6	>99.00%
GC73183	CDK8-IN-12 is an orally active, potent CDK8 inhibitor with a Ki of 14 nM.
GC74261	(R)-(+)-O-Demethylbuchenavianine	1364123-68-1	>98.00%
GC74261	(R)-(+)-O-Demetlbuchenavianine is an inhibitor for Cyclin-dependent kinases (CDK).
GC79117	8012–3246	421586-94-9	>99.50%
GC79117	8012-3246 is a selective PLK2 inhibitor with an IC 50 of 774.5 nM.
GC79759	SkQR1 hydroxide	1333381-77-3	>98%
GC79759	SkQR1 hydroxide is a mitochondrial targeted antioxidant.
GC80870	XL-418	871343-09-8	>95.00%
GC80870	XL-418 is an orally active dual Akt and p70S6K inhibitor with IC 50 s of 1 nM for Akt1 and 2 nM for p70S6K.
GC80873	Tovophyllin A	40738-44-1	>98%
GC80873	Tovophyllin A is an orally active xanthonoid compound.
GC80874	ARN25699	-	>98%
GC80874	ARN25699 is a kinase inhibitor with an IC 50 of 5.5 nM against GSK-3β, 2.2 nM against FYN-α, and 242.3 nM against DYRK1A, and it exhibits oral bioavailability.